A novel positron emission tomography contrast agent targeting cathepsin d shows preferential in vivo retention in an Alzheimer’s disease mouse model
Snir, Jonatan A., Suchy, Mojmir, Bindseil, Geron A., Chronik, Blaine A., Hudson, Robert H.E., Pasternak, Stephen H., Bartha, RobertVolume:
11
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2015.07.037
Date:
July, 2015
File:
PDF, 392 KB
english, 2015